These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20462258)

  • 1. Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approach.
    Procopiou PA; Barrett VJ; Bevan NJ; Biggadike K; Box PC; Butchers PR; Coe DM; Conroy R; Emmons A; Ford AJ; Holmes DS; Horsley H; Kerr F; Li-Kwai-Cheung AM; Looker BE; Mann IS; McLay IM; Morrison VS; Mutch PJ; Smith CE; Tomlin P
    J Med Chem; 2010 Jun; 53(11):4522-30. PubMed ID: 20462258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating arylsulfonamide groups.
    Procopiou PA; Barrett VJ; Bevan NJ; Biggadike K; Butchers PR; Coe DM; Conroy R; Edney DD; Field RN; Ford AJ; Guntrip SB; Looker BE; McLay IM; Monteith MJ; Morrison VS; Mutch PJ; Richards SA; Sasse R; Smith CE
    J Med Chem; 2009 Apr; 52(8):2280-8. PubMed ID: 19317397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
    Battram C; Charlton SJ; Cuenoud B; Dowling MR; Fairhurst RA; Farr D; Fozard JR; Leighton-Davies JR; Lewis CA; McEvoy L; Turner RJ; Trifilieff A
    J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of indole-derived long acting beta2-adrenoceptor agonists for the treatment of asthma and COPD.
    Brown AD; Bunnage ME; Glossop PA; Holbrook M; Jones RD; Lane CA; Lewthwaite RA; Mantell S; Perros-Huguet C; Price DA; Webster R
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6188-91. PubMed ID: 17897826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of higenamine in Radix Aconiti Lateralis Preparata as a beta2-adrenergic receptor agonist1.
    Bai G; Yang Y; Shi Q; Liu Z; Zhang Q; Zhu YY
    Acta Pharmacol Sin; 2008 Oct; 29(10):1187-94. PubMed ID: 18817623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.
    Slack RJ; Barrett VJ; Morrison VS; Sturton RG; Emmons AJ; Ford AJ; Knowles RG
    J Pharmacol Exp Ther; 2013 Jan; 344(1):218-30. PubMed ID: 23131596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification of indacaterol as an ultralong-acting inhaled beta2-adrenoceptor agonist.
    Baur F; Beattie D; Beer D; Bentley D; Bradley M; Bruce I; Charlton SJ; Cuenoud B; Ernst R; Fairhurst RA; Faller B; Farr D; Keller T; Fozard JR; Fullerton J; Garman S; Hatto J; Hayden C; He H; Howes C; Janus D; Jiang Z; Lewis C; Loeuillet-Ritzler F; Moser H; Reilly J; Steward A; Sykes D; Tedaldi L; Trifilieff A; Tweed M; Watson S; Wissler E; Wyss D
    J Med Chem; 2010 May; 53(9):3675-84. PubMed ID: 20402514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a rapidly metabolized, long-acting β(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.
    Procopiou PA; Barrett VJ; Biggadike K; Butchers PR; Craven A; Ford AJ; Guntrip SB; Holmes DS; Hughes SC; Jones AE; Looker BE; Mutch PJ; Ruston M; Needham D; Smith CE
    J Med Chem; 2014 Jan; 57(1):159-70. PubMed ID: 24359185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating a urea group.
    Procopiou PA; Barrett VJ; Ford AJ; Looker BE; Lunniss GE; Needham D; Smith CE; Somers G
    Bioorg Med Chem; 2011 Oct; 19(20):6026-32. PubMed ID: 21925889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating hydantoin or uracil rings.
    Procopiou PA; Barrett VJ; Bevan NJ; Butchers PR; Conroy R; Emmons A; Ford AJ; Jeulin S; Looker BE; Lunniss GE; Morrison VS; Mutch PJ; Perciaccante R; Ruston M; Smith CE; Somers G
    Bioorg Med Chem; 2011 Jul; 19(14):4192-201. PubMed ID: 21696967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of adamantyl-derived, inhaled, long acting beta(2)-adrenoreceptor agonists.
    Brown AD; Bunnage ME; Glossop PA; James K; Jones R; Lane CA; Lewthwaite RA; Mantell S; Perros-Huguet C; Price DA; Trevethick M; Webster R
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1280-3. PubMed ID: 18226900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR and the rational design of long-acting dual D2-receptor/beta 2-adrenoceptor agonists.
    Austin RP; Barton P; Bonnert RV; Brown RC; Cage PA; Cheshire DR; Davis AM; Dougall IG; Ince F; Pairaudeau G; Young A
    J Med Chem; 2003 Jul; 46(15):3210-20. PubMed ID: 12852752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and beta-adrenergic activity of a series of 3-(substituted-benzylideneaminoxy)propanolamine derivatives.
    Gentili D; Lapucci A; Macchia B; Macchia M; Martinelli A; Nencetti S; Orlandini E; Ferni G; Pinza M
    Farmaco; 1995; 50(7-8):519-26. PubMed ID: 7669190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists.
    Zheng W; Nikulin VI; Konkar AA; Vansal SS; Shams G; Feller DR; Miller DD
    J Med Chem; 1999 Jun; 42(12):2287-94. PubMed ID: 10377236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptamine-based human beta3-adrenergic receptor agonists. Part 1: SAR studies of the 7-position of the indole ring.
    Mizuno K; Sawa M; Harada H; Tateishi H; Oue M; Tsujiuchi H; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5959-62. PubMed ID: 15546707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional models for agonist and antagonist complexes with beta 2 adrenergic receptor.
    Kontoyianni M; DeWeese C; Penzotti JE; Lybrand TP
    J Med Chem; 1996 Oct; 39(22):4406-20. PubMed ID: 8893835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel, potent and selective human beta3-adrenergic receptor agonist.
    Nakajima Y; Hamashima H; Washizuka K; Tomishima Y; Ohtake H; Imamura E; Miura T; Kayakiri H; Kato M
    Bioorg Med Chem Lett; 2005 Jan; 15(2):251-4. PubMed ID: 15603933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of 5-hydroxy-4H-benzo[1,4]oxazin-3-ones as beta2-adrenoceptor agonists.
    Hoenke C; Bouyssou T; Tautermann CS; Rudolf K; Schnapp A; Konetzki I
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6640-4. PubMed ID: 19875286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
    Tanaka N; Tamai T; Mukaiyama H; Hirabayashi A; Muranaka H; Ishikawa T; Kobayashi J; Akahane S; Akahane M
    J Med Chem; 2003 Jan; 46(1):105-12. PubMed ID: 12502364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling.
    Baker JG; Hall IP; Hill SJ
    Mol Pharmacol; 2003 Dec; 64(6):1357-69. PubMed ID: 14645666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.